GlobeNewswire Inc | Feb 17, 2021 08:00AM EST

February 17, 2021

RALEIGH, N.C., Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its fourth quarter and full year 2020 financial results before the open of the U.S. financial markets onWednesday, March 10, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Timeto discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

Date: Wednesday, March 10, 2021Time: 8:30 AM Eastern TimeDomestic: 877-407-0789International: 201-689-8562Conference ID: 13715530Webcast: http://public.viavid.com/index.php?id=143193

AboutBioDelivery Sciences International, Inc.BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

2021BioDelivery Sciences International, Inc. All rights reserved.

Contact:Bob YedidLifeSci Advisors646-597-6989Bob@LifeSciAdvisors.com